Boundless Bio, Inc. (BOLD)
2.63
+0.01
(+0.38%)
USD |
NASDAQ |
Oct 05, 13:11
Boundless Bio Total Liabilities (Quarterly) : 7.768M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.768M |
| March 31, 2026 | 54.59M |
| December 31, 2025 | 58.40M |
| September 30, 2025 | 58.55M |
| June 30, 2025 | 56.76M |
| March 31, 2025 | 54.65M |
| December 31, 2024 | 55.77M |
| September 30, 2024 | 10.01M |
| Date | Value |
|---|---|
| June 30, 2024 | 8.957M |
| March 31, 2024 | 10.64M |
| December 31, 2023 | 256.98M |
| September 30, 2023 | 259.78M |
| June 30, 2023 | 258.80M |
| March 31, 2023 | |
| December 31, 2022 | 158.52M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
| Biogen, Inc. | 13.24B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 73.74M |
| Shareholders Equity (Quarterly) | 65.98M |
| Current Ratio | 9.481 |
| Net Debt Paydown Yield | 17.29% |